BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38617169)

  • 1.
    Qian LD; Zhou ZA; Li SQ; Liu J; Zhang SX; Ren JL; Wang W; Yang J
    Quant Imaging Med Surg; 2024 Apr; 14(4):3131-3145. PubMed ID: 38617169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature.
    Qian LD; Zhang SX; Li SQ; Feng LJ; Zhou ZA; Liu J; Zhang MY; Yang JG
    Insights Imaging; 2023 Nov; 14(1):205. PubMed ID: 38001240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
    Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J
    Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Qian LD; Feng LJ; Zhang SX; Liu J; Ren JL; Liu L; Zhang H; Yang J
    Quant Imaging Med Surg; 2023 Jan; 13(1):94-107. PubMed ID: 36620179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma
    Qian L; Yang S; Zhang S; Qin H; Wang W; Kan Y; Liu L; Li J; Zhang H; Yang J
    Front Med (Lausanne); 2022; 9():840777. PubMed ID: 35372427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
    Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
    BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification.
    Wu H; Wu C; Zheng H; Wang L; Guan W; Duan S; Wang D
    Eur Radiol; 2021 May; 31(5):3080-3089. PubMed ID: 33118047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of
    Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma.
    Chen X; Wang H; Huang K; Liu H; Ding H; Zhang L; Zhang T; Yu W; He L
    Front Oncol; 2021; 11():687884. PubMed ID: 34109133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an
    Feng L; Yao X; Lu X; Wang C; Wang W; Yang J
    Abdom Radiol (NY); 2024 Mar; 49(3):888-899. PubMed ID: 38315193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
    Wang G; Si Y; Liu J; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Yang M; Li X; Cai C; Liu C; Ma M; Qu W; Zhong S; Zheng E; Zhu H; Jin F; Shi H
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38127071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.
    Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X
    Front Oncol; 2021; 11():769272. PubMed ID: 34868999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.